Abstract:BACKGROUND:The new tetrandrine derivative is an anti-human liver cancer cell inhibitor which can be used to design and develop anti-human-liver-cancer drugs.OBJECTIVE:A quantitative structure-activity relationship (QSAR) model was established to predict the physical properties of new tetrandrine derivatives using their chemical structures.METHODS:The best descriptors were selected through CODESSA software to build a multiple linear regression model. Then, gene expression programming (GEP) was used to establish a nonlinear quantitative QSAR model with descriptors to predict the activity of a series of novel tetrandrine chemotherapy drugs. The best active compound 31 was subjected to molecular docking experiments through SYBYL software with a small fragment of the protein receptor (PDB ID:2J6M).RESULTS:Four descriptors were selected to build a multiple linear regression model with correlation coefficients R2, R2CV and S2 with the values of 0.8352, 0.7806 and 0.0119, respectively. The training and test sets with a correlation coefficient of 0.85 and 0.83 were obtained via an automatic problem-solving program (APS) using the four selected operators as parameters, with a mean error of 1.49 and 1.08. Compound 31 had a good docking ability with an overall score of 5.8892, a collision rate of -2.8004 and an extreme value of 0.9836.CONCLUSION:The computer-constructed drug molecular model reveals the factors affecting the activity of human hepatocellular carcinoma cells, which provides directions and guidance for the development of highly effective anti-humanhepatocellular- carcinoma drugs in the future.

QSAR study of 1,4-dihydropyridine calcium channel antagonists based on gene expression programming

Qsar Models for the Dermal Penetration of Polycyclic Aromatic Hydrocarbons Based on Gene Expression Programming

Quantitative Structure–activity Relationship: Promising Advances in Drug Discovery Platforms

Predicting the activity of drugs for a group of imidazopyridine anticoccidial compounds.

QSAR Research of Novel Tetrandrine Derivatives Against Human Hepatocellular Carcinoma.

Docking and QSAR studies of new 1,4-dihydropyridines containing 4(5)-chloro-2-methyl-5(4)-imidazolyl substituent

Neural networks in QSAR studies: Estimation and prediction of biological activity for N-(substituted phenoxyethyl)-cyclopropylamines

A QSAR study of 1,2-diarylimidazole cyclooxygenase-2 inhibitors

Improved Gene Expression Programming and Its Application to QSAR

Inhibition mechanism exploration of quinoline derivatives as PDE10A inhibitors by in silico analysis

In silico design novel dihydropyrimio[4, 5-d]pyrimidine derivatives as inhibitors for colony-stimulating factor-1 receptor based on 3D-QSAR, molecular docking and molecular dynamics simulation

A combination of pharmacophore modeling, atom-based 3D-QSAR, molecular docking and molecular dynamics simulation studies on PDE4 enzyme inhibitors

Three-dimensional quantitative structure–activity relationship study for analogues of TQXs using CoMFA and CoMSIA

A Linear and Nonlinear QSAR Analysis of Benzimidazole Derivative XY123 in Prostate Cancer Treatment

QSAR Studies of Imidazopyridine Derivatives As Et-PKG Inhibitors Using the PSO-SVM Approach

Activity prediction of hepatitis C virus NS5B polymerase inhibitors of pyridazinone derivatives

QSAR study of fiavonoids derivatives as p56lck protein tyrosine kinase inhibitors using GA-SVM

QSAR study of flavonoids inhibitors of the PIM-1 kinase

QSAR study of tetrahydropteridin derivatives as polo-like kinase 1(PLK1) Inhibitors with molecular docking and dynamics study

Enhanced QSAR model performance by integrating structural and gene expression information.

Qsar of Pyrazole Oxadiazole Derivatives As S1p1 Agonists Studied by Comfa, Comsia and Docking